The potential of TB treatment 8 weeks

Published Date: 08 Mar 2023

While some say this strategy's failure rate is "too high," it's one step closer to the "white grail" of a shorter 24-week formula.

Read Full News

Latest News

US CDC Seeks Staff for Ebola Screening as Outbreak Response Expands

The U.S. Centers for Disease Control and Prevention has asked staff to volunteer for urgent deployment to support ⁠Ebola screening at the country's entry points, according...

mRNA Shot Offers Efficacy for Influenza-Like Illness

In older adults, a single dose of the mRNA-1010 vaccine shows superior efficacy to the standard-dose inactivated seasonal influenza vaccine in the prevention of influenza-like illness.

Red Cross Mourns Death of Three Volunteers From Ebola

The Red Cross on Saturday paid tribute to three volunteers who ⁠are believed to have died after contracting Ebola while handling bodies.

US Adds Atlanta Area Airport for Ebola Screening, CDC Says

Americans coming back from the Democratic Republic of the Congo, ⁠Uganda or South Sudan now have a second entry point for returning ⁠to the United States, with the CDC on...

US FDA Advisers to Weigh Updating 2026-27 COVID Vaccines for XFG Variant

Advisers to the U.S. Food and Drug Administration will discuss whether COVID-19 vaccines should be updated to target the latest circulating XFG ⁠subvariant for the 2026-27...

Shingles Shot Shows Short-Term Safety in People With HIV

In people living with HIV, the adjuvanted recombinant subunit herpes zoster vaccine shows a favorable short-term safety and tolerability profile.

Todays Updates

FDA Approves Novel Targeted Therapy for Rare Blood Cancer

The CD123-directed antibody and alkylating agent conjugate led to complete remission or clinical complete remission in nearly 70% of treatment-naive patients in a single arm study.

Durvalumab Plus BCG Earns FDA Nod for Bladder Cancer

The combination therapy is approved for BCG-naive patients with high-risk non-muscle-invasive disease.

Todays Updates

FDA Approves Novel Targeted Therapy for Rare Blood Cancer

The CD123-directed antibody and alkylating agent conjugate led to complete remission or clinical complete remission in nearly 70% of treatment-naive patients in a single arm study.

Durvalumab Plus BCG Earns FDA Nod for Bladder Cancer

The combination therapy is approved for BCG-naive patients with high-risk non-muscle-invasive disease.

Latest News

The U.S. Centers for Disease Control and Prevention has asked staff to volunteer for urgent deployment to support ⁠Ebola screening at the country's entry points, according...

In older adults, a single dose of the mRNA-1010 vaccine shows superior efficacy to the standard-dose inactivated seasonal influenza vaccine in the prevention of influenza-like illness.

The Red Cross on Saturday paid tribute to three volunteers who ⁠are believed to have died after contracting Ebola while handling bodies.

Americans coming back from the Democratic Republic of the Congo, ⁠Uganda or South Sudan now have a second entry point for returning ⁠to the United States, with the CDC on...

Advisers to the U.S. Food and Drug Administration will discuss whether COVID-19 vaccines should be updated to target the latest circulating XFG ⁠subvariant for the 2026-27...

In people living with HIV, the adjuvanted recombinant subunit herpes zoster vaccine shows a favorable short-term safety and tolerability profile.

News All Time

Britain Gets Experimental Drug From Japan to Bolster Hantavirus Response

Britain has received supplies of the antiviral drug favipiravir from Japan as part of its response to a deadly hantavirus ⁠outbreak linked to the Hondius cruise liner, the...

Adult Dies of Hantavirus in Colorado, State Health Officials Say

An adult in Colorado has died after a confirmed ⁠case of hantavirus that is not linked to a recent outbreak aboard ⁠a cruise ship in the Atlantic, Colorado Department of...

Rapid Tests: What We Gain in Speed, We Risk in Certainty

Dr Alok Patel examines the trade-offs behind rapid testing, from diagnostic accuracy and patient behavior to cost, workflow, and clinical judgment.

FDA Drug Center Head Fired After Commissioner's Exit, Replaced by Davis

The acting head of the U.S. Food and Drug Administration's drug center, Tracy Beth Hoeg, was fired on Friday, according to her ⁠social media post, and has been replaced by...

Mexico Suspends Imports of Some US Pork Products Over Virus

Mexico has suspended imports from the U.S. of breeding pigs, semen, viscera and pork offal products after ⁠U.S. authorities detected pseudorabies virus antibodies in some...

U.S. Reports no Hantavirus Cases From Cruise Outbreak, Monitors 41

There are no confirmed cases in the United States of the Andes hantavirus outbreak that killed three people aboard ⁠a luxury cruise ship this month, U.S. health officials...

US Supreme Court Lets Abortion Pill Mail Delivery Continue

The U.S. Supreme Court on Thursday ensured that the abortion pill can continue to be prescribed through telemedicine and dispensed by mail, as the justices restored for now...

Real-World Data Support Maribavir for Posttransplant CMV

Maribavir is an effective and well-tolerated option for cytomegalovirus infection and disease among hematopoietic cell transplant recipients.

Biomarkers Spot Invasive Aspergillosis Post-Lung Transplant

RNA testing may help assess the consequences of common environmental mold.

South Africa: Brit With Hantavirus Gradually Improving

The condition of a British man who was admitted ⁠to a hospital in Johannesburg after falling ill with hantavirus aboard ⁠a luxury cruise ship is gradually improving.

Pregnancy vs Postpartum Flare Rates Differ in RA and SpA

Patients with rheumatoid arthritis are more likely to experience flares during the early postpartum period than during pregnancy; however, flare rates in those with spondyloarthritis remain stable.

WHO Says Seven Cases Of Hantavirus Confirmed From Cruise Ship

Seven cases of the ⁠Andes hantavirus have now been confirmed among people ⁠who were passengers on board the ⁠cruise ship, the ‌World Health Organization said on...

A Child's First Flu May Set the Tone for Immunity

New research shows that a child's earliest encounter with the virus can 'imprint' the immune system, shaping how their antibodies respond to future infections.

First Lyme Vaccine in Decades Nears Approval

Positive phase 3 findings may reshape Lyme disease prevention among people with frequent tick exposure across endemic regions.

Prior Maternal Syphilis Boosts Congenital Infection Risk

A history of adequately treated syphilis before pregnancy is associated with more than a 100-fold increase in congenital syphilis risk.

US CDC Classifies Hantavirus Outbreak as 'level 3' Emergency Response, ABC News Reports

The ⁠U.S. Centers ⁠for Disease ⁠Control and ‌Prevention has classified the hantavirus ‌outbreak as 'level 3' ‌emergency ‌response, the ⁠lowest ‌level ⁠of emergency...

Recommended News For You

Pirtobrutinib May Be Beneficial in Follicular Lymphoma with Severe Pretreatment.

Mouse study finds tirzepatide slowed obesity-associated breast cancer growth

Is Vitamin D a Key to Better Breast Cancer Survival?

A researcher has found that yoga exhibits the "most improvement" in helping long-term cancer survivors restore their brain health.

Why are so many young adults getting cancer?

In high-risk muscle invasive urothelial cancer, adjuvant pembrolizumab improves disease-free survival.

A prostate cancer risk prediction algorithm could help target men at highest risk

Recommended Articles For You

Respiratory Ramifications of Systemic Disease: A Comprehensive Review 

The Latest Research on Basal Cell Carcinoma: New Developments in Diagnosis and Cure  

The Statistical Evolution of Cancer Staging and Its Precision Impact on Prognosis and Therapy in Cancer Staging 2025 

Exploring the Causes and Treatments of Bacterial Keratitis: A Comprehensive Guide 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Lung cancer screening adherence rates decline annually after baseline screening

2.

MRI-guided radiation therapy improves quality of life with fewer side effects in patients with localized cancer. JAMA

3.

Weight-Based and Fixed-Dose Pembrolizumab Compared in NSCLC

4.

World's premier cancer institute faces crippling cuts and chaos

5.

Zebrafish models offer fast, effective guidance for personalized therapies for kids with high-risk cancer

1.

The Power of Romiplostim in Treating Low Platelet Counts 

2.

Cancer Diagnosis in 2025: Innovations, Education, and Evolving Clinical Strategies

3.

Case Study: Combining Targeted Therapy with Immunotherapy for Metastatic Melanoma

4.

The Different Types of Cysts and Why They Occur: Insights from a Dermatologist 

5.

Protein S-Palmitoylation in Cancer: A Novel Target in Immunotherapy & Treatment

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Dissecting Molecular differences between EGFR Exon 19 deletion and Exon 21 L858R Mutations

2.

The Era of Targeted Therapies for ALK+ NSCLC: A Paradigm Shift

3.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part V

4.

An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- The Conclusion

5.

Incidence of Lung Cancer- An Overview to Understand ALK Rearranged NSCLC

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot